NCT06366048

Brief Summary

The post-hepatotectomy liver failure (PHLF) is still the most worrisome complication of hepatic resection. Surgeons have always been making efforts to preoperatively predict PHLF using kinds of techniques, scoring systems, and variables. The investigators of this study tried to create an individual predictive model based on the variable, resected normal parenchymal volume (RNLV), then assessing the performance and value of the model in clinical practice.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,600

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Dec 2022

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Dec 2022Dec 2026

Study Start

First participant enrolled

December 1, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

April 10, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

4.1 years

First QC Date

April 10, 2024

Last Update Submit

April 9, 2026

Conditions

Keywords

resected normal parenchymal volume (RNLV)postoperative hepatectomy liver failure (PHLF)future liver remnant (FLR)

Outcome Measures

Primary Outcomes (1)

  • Probability of PHLF was predicted with our individual model based on RNLV.

    In our center, an increase international normalized ratio greater than 1.15 and concomitant hyperbilirubinemia more than 23μmol/L on or after postoperative day 5 would be defined as PHLF, according to the International Study Group of Liver Surgery.

    postoperative day 1 to day 30.

Study Arms (2)

PHLF group

One group was defined as post-operative liver failure accroding to the PHLF definition of 50-50 criteria and ISGLS criteria.

Diagnostic Test: the different definitions of PHLF according to 50-50 criteria and ISGLS criteria

No PHLF group

One group was defined as no post-operative liver failure accroding to the PHLF definition of 50-50 criteria nor ISGLS criteria.

Interventions

Our study respectively defined the PHLF according to the 50-50 criteria and the ISGLS criteria in literature review.

PHLF group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1133 consecutive patients diagnosed with hepatocellular carcinoma (HCC) and intracholangiocarcinoma underwent hepatectomies.

You may qualify if:

  • selective hepatectomies;
  • histologically confirmed as HCC and ICC
  • complete and accessible data

You may not qualify if:

  • any history of Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)
  • any history of portal vein embolism (PVE)
  • any history of tumor rupture
  • emergency surgery
  • pathologically diagnosed with neither HCC nor ICC
  • concomitant resection of gastrointestinal organs, spleenectomy or other organs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Mengchao Hepatobiliary Hospital of Fujian Medical University

Fujian, Shanghai Municipality, China

RECRUITING

The Third Affiliated Hospital of Naval Medical University

Shanhai, Shanghai Municipality, 201800, China

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen, Mengchao Hepatobiliary Hospital of Fujian Medical University

Shenzhencun, Shanghai Municipality, China

RECRUITING

Related Publications (4)

  • Ioannou GN, Green P, Kerr KF, Berry K. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification. J Hepatol. 2019 Sep;71(3):523-533. doi: 10.1016/j.jhep.2019.05.008. Epub 2019 May 28.

    PMID: 31145929BACKGROUND
  • Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2020 Aug;9(4):452-463. doi: 10.21037/hbsn-20-480.

    PMID: 32832496BACKGROUND
  • Renner P, Schuhbaum J, Kroemer A, Zeman F, Loss M, Lang SA, Geissler EK, Schlitt HJ, Farkas SA. Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma. Langenbecks Arch Surg. 2016 Feb;401(1):43-53. doi: 10.1007/s00423-015-1359-y. Epub 2015 Dec 1.

    PMID: 26627084BACKGROUND
  • Xie QS, Chen ZX, Zhao YJ, Gu H, Geng XP, Liu FB. Systematic review of outcomes and meta-analysis of risk factors for prognosis after liver resection for hepatocellular carcinoma without cirrhosis. Asian J Surg. 2021 Jan;44(1):36-45. doi: 10.1016/j.asjsur.2020.08.019. Epub 2020 Sep 28.

    PMID: 32988708BACKGROUND

MeSH Terms

Conditions

Liver Failure

Condition Hierarchy (Ancestors)

Hepatic InsufficiencyLiver DiseasesDigestive System Diseases

Study Officials

  • Yuan-yuan Wang

    Eastern Hepatobiliary Surgery Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
a clinical resident of general surgery department

Study Record Dates

First Submitted

April 10, 2024

First Posted

April 15, 2024

Study Start

December 1, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 14, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

After we published our study paper, we would like to share IPD attached to our paper as website links.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After our paper published officially. The final time would be end of March 31st,2024.
Access Criteria
Not sure now.

Locations